The Meteoric Surge of Landos Biopharma: An Acquisition Tale of Market Movers

Witness the breathtaking ascent of Landos Biopharma, Inc. LABP, a sight that would make even the most seasoned investor’s heart race, as it climbs to the peaks of the market charts on the wings of acquisition news.

AbbVie Inc. ABBV and Landos Biopharma have etched a historic tale of collaboration, crafting a definitive agreement that will see AbbVie acquiring the promising Landos.

Today, Landos Biopharma shares catapulted an astonishing 171.2% to $21.70, painting a vibrant picture of market enthusiasm and investor optimism.

Amidst this resplendent rise, let’s take a stroll through the enchanted forest of today’s mid-day session, where other stocks dance to the melody of market dynamics.

Exemplary Gains

Next.e.GO N.V. EGOX gracefully leaped 85.8% to $0.0730, bouncing back with vigor after a somber Friday.
Altamira Therapeutics Ltd. CYTO ascended 70.1% to $2.9255, fueled by a harmonious collaboration with Univercells Group on mRNA vaccines delivered via nanoparticles.
MicroAlgo Inc. MLGO scaled 34.3% to $5.40, regaining its footing after a brief stumble on Friday.
XTL Biopharmaceuticals Ltd. XTLB surged 32.4% to $3.4690, eagerly pursuing a binding term sheet to embrace the share capital of Social Proxy.
Nkarta, Inc. NKTX flourished by 23.3% to $11.00, after orchestrating a splendid $240 million underwritten offering.
Target Hospitality Corp. TH surged 21.3% to $10.82, as it waltzed to the melodies of a buyout offer from TDR Capital.
Swvl Holdings Corp. SWVL gracefully rose by 21.2% to $11.26, captivating the attention of market spectators.
Brainstorm Cell Therapeutics Inc. BCLI surged by 21% to $0.6949, showcasing a remarkable performance on the market stage.
Lucid Group, Inc. LCID climbed a notable 18.7% to $3.29, echoing the jubilant announcement of a $1 billion investment by an affiliate of PIF.
Sagimet Biosciences Inc. SGMT surged elegantly by 16.9% to $5.27, regaling in the reflections of its fiscal year results and the esteemed appointments to its Board of Directors.
Ocugen, Inc. OCGN joyously leaped 16.4% to $1.9101, heralding the Third Circuit Court of Appeals’ decision to dismiss, with prejudice, the consolidated securities class action lawsuits against Ocugen.
Flora Growth Corp. FLGC charmed the market dance floor with a 15.2% rise to $1.8206, following a flamboyant surge of approximately 34% on the previous Friday.
Forge Global Holdings, Inc. FRGE graciously gained 14.5% to $2.67, building on its 13% rise from the preceding Friday.
Cipher Mining Inc. CIFR elegantly soared by 14.1% to $5.27, showcasing a market performance that resonated with investors.
GoodRx Holdings, Inc. GDRX ascended by a notable 13.5% to $7.44, basking in the glow of the upgraded stock status from Wells Fargo and the announcement of a $10 price target.
Neuronetics, Inc. STIM gracefully climbed 13.5% to $4.80, as NeuroStar® Advanced Therapy secured FDA clearance as a pioneering first-line add-on treatment for adolescents battling depression.
Lichen China Limited LICN rose by 12.6% to $1.16, delighting investors with the announcement of the AI-powered Lichen AI Robot, an innovation steeped in GPT-based technology.
UroGen Pharma Ltd. URGN rose by a commendable 11.1% to $17.51, marking a significant stride on the market terrain.
Cazoo Group Ltd CZOO gained 11% to $4.12, reclaiming lost ground after a 21% decline on the preceding Friday.
Salarius Pharmaceuticals, Inc. SLRX rose by 10.5% to $0.6849, propelled by the reverberations of fourth-quarter results in the market arena.
MicroStrategy Incorporated MSTR gained a solid 10.3% to $1,680.00, maintaining its course amidst the Bitcoin tides washing over the market shores.
Masimo Corporation MASI jumped by 9.5% to $147.72, following the announcement of managerial authorization to explore a proposed separation of its consumer business.
Foot Locker, Inc. FL shares rose by 8.4% to $26.45, buoyed by Evercore ISI Group’s upgraded stock status and raised price target, echoing a promising outlook for the stock.
GameStop Corp. GME gained 8.2% to $14.17, embracing market movements with a steady pace.
Esperion Therapeutics, Inc. ESPR rose by 6.6% to $2.40, after the FDA broadened the labels for NEXLETOL and NEXLIZET, paving the way for heart attack and cardiovascular procedure prevention irrespective of statin use.
Micron Technology, Inc. MU ascended by 5.1% to $115.81, reflecting a steady climb in the market landscape.

The Tempered Fall

Sintx Technologies, Inc.

Market Meltdown: A Red Day for Investors

Amidst Market Volatility, Top Companies Witness Significant Stock Plunges
- SINT shares took a nosedive by 49.1% to $0.0471 after the company revealed pricing for a $1.3 million public offering of common stock.
- Akanda Corp. was not spared either, with AKAN plummeting 38.1% to $0.1507 following the announcement of an underwritten public offering.
- Fisker Inc. witnessed a steep drop of 28.1% to $0.0897 after receiving notice that negotiations with a significant automaker for a potential transaction came to an abrupt halt.
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports, and breaking news that affect the stocks you care about.